CROI 2010 Reminder
AIDS WATCH
Abstracts for the 2010 Retrovirus Conference are due October 6, 2009. The conference will take place February 16–19, 2010, in San Francisco.
Non–AIDS-Defining Cancer Is More Common in HIV-Infected Than in HIV-Uninfected Men
SUMMARY AND COMMENT
August 10, 2009
Keith Henry, MD
In the U.S. VA Healthcare System, the incidence of non–AIDS-defining malignancies was 60% higher in HIV-infected patients than in matched HIV-uninfected patients.
Reviewing:
Bedimo RJ et al., J Acquir Immune Defic Syndr 2009 Jul 16
Impressive Results with Raltegravir in Treatment-Naive HIV Patients
SUMMARY AND COMMENT
August 10, 2009
Paul E. Sax, MD
Rates of virologic suppression were similar between raltegravir and efavirenz, but drug-related adverse events were less common with raltegravir.
Reviewing:
Lennox JL et al., Lancet 2009 Aug 3
Emery S and Winston A., Lancet 2009 Aug 3
Identifying Patients with Acute HIV Infection and Their Partners
SUMMARY AND COMMENT
In North Carolina, a protocol for negative or indeterminate HIV-antibody results that involved nucleic acid amplification testing, confirmatory antibody testing, and follow-up interviews led to identification of newly infected partners of newly infected patients.
Reviewing:
Moore ZS et al., J Acquir Immune Defic Syndr 2009 Jun 26
Readers vs. Experts on the Question of Informed Consent and Possible Occupational Exposure to HIV
LETTER TO READERS
August 10, 2009
Paul E. Sax, MD
Experts say observe the law; readers say test the patient.
Monitoring HIV Patients' Kidney Function in Clinical Practice
FEATURE
August 3, 2009
Lynda Anne Szczech, MD, MSCE
What is known about kidney disease in other clinical contexts can help guide HIV care providers in monitoring the kidney function of their patients.
Reviewing:
Nickolas TL et al., Ann Intern Med 2008 Jun 3; 148:810
Paragas N et al., J Am Soc Nephrol 2009 Jul 23
Levey AS et al., Ann Intern Med 2009 May 5; 150:604
Cockcroft DW and Gault MH., Nephron 1976 Jan; 16:31
Levey AS et al., J Am Soc Nephrol 2000 ; 11:A0828
Ginsberg JM et al., N Engl J Med 1983 Dec 22; 309:1543
National Kidney Foundation., 2002
Szczech LA et al., AIDS 2007 May 11; 21:1003
Gupta SK et al., Clin Infect Dis 2005 Jun 1; 40:1559
Szczech LA et al., Kidney Int 2002 Jan; 61:195
Kopp JB et al., Nat Genet 2008 Oct; 40:1175
Reich HN et al., J Am Soc Nephrol 2007 Dec; 18:3177
Loss to Follow-Up Worsens Outcomes for HIV Patients, Even If They Return to Care
SUMMARY AND COMMENT
August 3, 2009
Rochelle P. Walensky, MD, MPH
Mortality risk was five times higher among HIV patients in northern France who returned to care after being lost to follow-up than among those who were never lost.
Reviewing:
Ndiaye B et al., AIDS 2009 Jun 15
Sex-Drug Use Increases HIV Risk for MSM
SUMMARY AND COMMENT
In a cohort of HIV-uninfected MSM, the use of poppers, stimulants, or erectile dysfunction drugs significantly increased the risk for acquiring HIV.
Reviewing:
Ostrow DG et al., J Acquir Immune Defic Syndr 2009 Jul; 51:349
Stuck in the Middle
ANTIRETROVIRAL ROUNDS
A clinician sustains a needlestick from a patient who refuses HIV testing. An HIV physician, an attorney, and an ethicist weigh provide weigh in on how best to manage.
Death from Non–AIDS-Related Causes: Another Risk of Immunodeficiency
SUMMARY AND COMMENT
Non–AIDS-related deaths accounted for more than half of all deaths in this cohort; the risk was reduced with a higher CD4-cell count.
Reviewing:
Marin B et al., AIDS 2009 Jun 30